TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmarelations AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
222,130
|
200,431
|
150,261 |
Financial expenses |
289
|
231
|
86 |
Earnings before taxes |
14,586
|
15,458
|
14,511 |
EBITDA |
14,296
|
15,600
|
14,620 |
Total assets |
80,873
|
65,626
|
54,382 |
Current assets |
80,485
|
65,186
|
53,979 |
Current liabilities |
31,182
|
24,608
|
23,148 |
Equity capital |
46,440
|
35,126
|
24,368 |
- share capital |
71
|
67
|
73 |
Employees (average) |
227
|
197
|
146 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
57.4%
|
53.5%
|
44.8% |
Turnover per employee |
979
|
1,017
|
1,029 |
Profit as a percentage of turnover |
6.6%
|
7.7%
|
9.7% |
Return on assets (ROA) |
18.4%
|
23.9%
|
26.8% |
Current ratio |
258.1%
|
264.9%
|
233.2% |
Return on equity (ROE) |
31.4%
|
44.0%
|
59.5% |
Change turnover |
20,667
|
62,341
|
34,985 |
Change turnover % |
10%
|
45%
|
30% |
Chg. No. of employees |
30
|
51
|
34 |
Chg. No. of employees % |
15%
|
35%
|
30% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.